Skip to main content
. 2016 Jun 23;68(7):907–913. doi: 10.1002/acr.22763

Figure 4.

Figure 4

Improvements in patient pain over 2 years in responder and nonresponder patient subgroups, in an intent‐to‐treat population, defined by clinical response criteria: (A) American College of Rheumatology 20% improvement (ACR20) response, (B) Simplified Disease Activity Index (SDAI) low disease activity (LDA), and (C) SDAI remission. All patients with baseline and postbaseline measurements were used for this analysis. Error bars represent SEM. SC = subcutaneous; VAS = visual analog scale.